Colorado Medicaid Outcomes-Based Contracting Gets Green Light From CMS
Executive Summary
State is third to obtain approval from CMS to negotiate supplemental rebates as part of value-based contract. Arrangements would be exempt from “best price” requirements.
You may also be interested in...
Rx Importation: Califf's Switch Means US FDA Commissioners No Longer Uniformly Opposed
In JAMA editorial, former FDA chief supports drug importation under narrow circumstances as a way to reduce drug prices, marking a shift from his previous stance on the issue and that of other past agency heads. Essay, co-authored by former CMS Acting Administrator Andy Slavitt, calls importation "a workaround born of desperation."
Outcomes-Based Contracts May Be Negotiated By Michigan Medicaid
Michigan follows Oklahoma in gaining approval to negotiate supplemental rebates in the context of value-based contracts for drugs. Oklahoma now has four novel contracts in place.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.